Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global Drug Developing Platforms by Artificial Intelligence (AI) market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Antidote
IBM
Cambridge Cancer Genomics
Atomwise
Insilico Medicine
Turbine
Google
Deep Genomics
Row Analytics
Microsoft
Genpact
BenevolentAI
AiCure
Schrödinge
Biovista
GNS Healthcare
Calico
BERG
NuMedii
Iktos
Standigm
Nuritas
Sirenas
NVIDIA Corporation
Cloud Pharmaceuticals
Concerto HealthAI (SymphonyAI)
Cyclica
Exscientia
Transcriptic
Kairntech
By Types:
Software
System
Service
Product
Others
By Applications:
Generate Data and Models
Repurpose Existing Drugs
Generate Novel Drug Candidates
Validate and Optimize Drug Candidates
Design Drugs
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Analysis from 2023 to 2028
1.5.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Drug Developing Platforms by Artificial Intelligence (AI) Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Drug Developing Platforms by Artificial Intelligence (AI) Industry Impact
Chapter 2 Global Drug Developing Platforms by Artificial Intelligence (AI) Competition by Types, Applications, and Top Regions and Countries
2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) (Volume and Value) by Type
2.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Market Share by Type (2017-2022)
2.1.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue and Market Share by Type (2017-2022)
2.2 Global Drug Developing Platforms by Artificial Intelligence (AI) (Volume and Value) by Application
2.2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Market Share by Application (2017-2022)
2.2.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue and Market Share by Application (2017-2022)
2.3 Global Drug Developing Platforms by Artificial Intelligence (AI) (Volume and Value) by Regions
2.3.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Regions (2017-2022)
4.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
4.10 South America Drug Developing Platforms by Artificial Intelligence (AI) Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
5.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
5.1.1 North America Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
5.2 North America Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
5.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
5.4 North America Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
5.4.1 United States Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
5.4.2 Canada Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
5.4.3 Mexico Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 6 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
6.1 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
6.1.1 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
6.2 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
6.3 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
6.4 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
6.4.1 China Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
6.4.2 Japan Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
6.4.3 South Korea Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 7 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
7.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
7.1.1 Europe Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
7.2 Europe Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
7.3 Europe Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
7.4 Europe Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
7.4.1 Germany Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.2 UK Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.3 France Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.4 Italy Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.5 Russia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.6 Spain Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.7 Netherlands Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.8 Switzerland Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
7.4.9 Poland Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 8 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
8.1 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
8.1.1 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
8.2 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
8.3 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
8.4 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
8.4.1 India Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
8.4.2 Pakistan Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
9.1 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
9.1.1 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
9.2 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
9.3 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
9.4 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
9.4.1 Indonesia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
9.4.2 Thailand Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
9.4.3 Singapore Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
9.4.4 Malaysia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
9.4.5 Philippines Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
9.4.6 Vietnam Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
9.4.7 Myanmar Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 10 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
10.1 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
10.1.1 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
10.2 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
10.3 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
10.4 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
10.4.1 Turkey Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.3 Iran Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.5 Israel Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.6 Iraq Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.7 Qatar Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.8 Kuwait Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
10.4.9 Oman Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 11 Africa Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
11.1 Africa Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
11.1.1 Africa Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
11.2 Africa Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
11.3 Africa Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
11.4 Africa Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
11.4.1 Nigeria Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
11.4.2 South Africa Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
11.4.3 Egypt Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
11.4.4 Algeria Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
11.4.5 Morocco Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 12 Oceania Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
12.1 Oceania Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
12.2 Oceania Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
12.3 Oceania Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
12.4 Oceania Drug Developing Platforms by Artificial Intelligence (AI) Consumption by Top Countries
12.4.1 Australia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
12.4.2 New Zealand Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 13 South America Drug Developing Platforms by Artificial Intelligence (AI) Market Analysis
13.1 South America Drug Developing Platforms by Artificial Intelligence (AI) Consumption and Value Analysis
13.1.1 South America Drug Developing Platforms by Artificial Intelligence (AI) Market Under COVID-19
13.2 South America Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Types
13.3 South America Drug Developing Platforms by Artificial Intelligence (AI) Consumption Structure by Application
13.4 South America Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume by Major Countries
13.4.1 Brazil Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
13.4.2 Argentina Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
13.4.3 Columbia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
13.4.4 Chile Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
13.4.5 Venezuela Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
13.4.6 Peru Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
13.4.8 Ecuador Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Drug Developing Platforms by Artificial Intelligence (AI) Business
14.1 Antidote
14.1.1 Antidote Company Profile
14.1.2 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.1.3 Antidote Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 IBM
14.2.1 IBM Company Profile
14.2.2 IBM Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.2.3 IBM Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Cambridge Cancer Genomics
14.3.1 Cambridge Cancer Genomics Company Profile
14.3.2 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.3.3 Cambridge Cancer Genomics Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Atomwise
14.4.1 Atomwise Company Profile
14.4.2 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.4.3 Atomwise Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Insilico Medicine
14.5.1 Insilico Medicine Company Profile
14.5.2 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.5.3 Insilico Medicine Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Turbine
14.6.1 Turbine Company Profile
14.6.2 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.6.3 Turbine Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Google
14.7.1 Google Company Profile
14.7.2 Google Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.7.3 Google Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Deep Genomics
14.8.1 Deep Genomics Company Profile
14.8.2 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.8.3 Deep Genomics Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Row Analytics
14.9.1 Row Analytics Company Profile
14.9.2 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.9.3 Row Analytics Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Microsoft
14.10.1 Microsoft Company Profile
14.10.2 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.10.3 Microsoft Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Genpact
14.11.1 Genpact Company Profile
14.11.2 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.11.3 Genpact Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.12 BenevolentAI
14.12.1 BenevolentAI Company Profile
14.12.2 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.12.3 BenevolentAI Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.13 AiCure
14.13.1 AiCure Company Profile
14.13.2 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.13.3 AiCure Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.14 Schrödinge
14.14.1 Schrödinge Company Profile
14.14.2 Schrödinge Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.14.3 Schrödinge Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.15 Biovista
14.15.1 Biovista Company Profile
14.15.2 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.15.3 Biovista Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.16 GNS Healthcare
14.16.1 GNS Healthcare Company Profile
14.16.2 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.16.3 GNS Healthcare Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.17 Calico
14.17.1 Calico Company Profile
14.17.2 Calico Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.17.3 Calico Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.18 BERG
14.18.1 BERG Company Profile
14.18.2 BERG Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.18.3 BERG Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.19 NuMedii
14.19.1 NuMedii Company Profile
14.19.2 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.19.3 NuMedii Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.20 Iktos
14.20.1 Iktos Company Profile
14.20.2 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.20.3 Iktos Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.21 Standigm
14.21.1 Standigm Company Profile
14.21.2 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.21.3 Standigm Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.22 Nuritas
14.22.1 Nuritas Company Profile
14.22.2 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.22.3 Nuritas Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.23 Sirenas
14.23.1 Sirenas Company Profile
14.23.2 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.23.3 Sirenas Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.24 NVIDIA Corporation
14.24.1 NVIDIA Corporation Company Profile
14.24.2 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.24.3 NVIDIA Corporation Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.25 Cloud Pharmaceuticals
14.25.1 Cloud Pharmaceuticals Company Profile
14.25.2 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.25.3 Cloud Pharmaceuticals Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.26 Concerto HealthAI (SymphonyAI)
14.26.1 Concerto HealthAI (SymphonyAI) Company Profile
14.26.2 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.26.3 Concerto HealthAI (SymphonyAI) Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.27 Cyclica
14.27.1 Cyclica Company Profile
14.27.2 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.27.3 Cyclica Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.28 Exscientia
14.28.1 Exscientia Company Profile
14.28.2 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.28.3 Exscientia Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.29 Transcriptic
14.29.1 Transcriptic Company Profile
14.29.2 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.29.3 Transcriptic Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.30 Kairntech
14.30.1 Kairntech Company Profile
14.30.2 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Product Specification
14.30.3 Kairntech Drug Developing Platforms by Artificial Intelligence (AI) Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Drug Developing Platforms by Artificial Intelligence (AI) Market Forecast (2023-2028)
15.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Value and Growth Rate Forecast (2023-2028)
15.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption Forecast by Type (2023-2028)
15.3.2 Global Drug Developing Platforms by Artificial Intelligence (AI) Revenue Forecast by Type (2023-2028)
15.3.3 Global Drug Developing Platforms by Artificial Intelligence (AI) Price Forecast by Type (2023-2028)
15.4 Global Drug Developing Platforms by Artificial Intelligence (AI) Consumption Volume Forecast by Application (2023-2028)
15.5 Drug Developing Platforms by Artificial Intelligence (AI) Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Services |
Pages : 100 |
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Services |
Pages : 120 |
| Price : US$ 3,500 |
Date : Nov 2024 |
| Category : Services |
Pages : 122 |
Request Sample 
Request Discount 
Inquire Before Buy
